A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
Clinical trial NCT07778836 · RECRUITING
Trial details
- NCT number
- NCT07778836
- Sponsor
- Larimar Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-05
- Primary completion
- 2029-07-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.